Page last updated: 2024-10-30

loperamide and Acute Myelogenous Leukemia

loperamide has been researched along with Acute Myelogenous Leukemia in 1 studies

Loperamide: One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
loperamide : A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhao, H1
Lu, J1
Yan, T1
Han, F1
Sun, J1
Yin, X1
Chen, L2
Shen, C1
Wunderlich, M1
Yun, W1
Yang, L1
Su, D1
Bohlander, SK1
Wang, F1
Mulloy, JC1
Li, C1
Chen, J1
Huang, H1
Jiang, X1

Other Studies

1 other study available for loperamide and Acute Myelogenous Leukemia

ArticleYear
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2.
    Cell reports, 2022, 01-25, Volume: 38, Issue:4

    Topics: Analgesics, Opioid; Animals; Cell Proliferation; Cell Survival; Dioxygenases; DNA-Binding Proteins;

2022